It is a link for moving within the page.

  1. HOME
  2. About Otsuka
  3. News Releases
  4. 2020
  5. Otsuka Filed Application in Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migraine

July 29, 2020

Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals

Otsuka Filed Application in Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migraine豆奶短视频app下载

Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that an application has been submitted to the Pharmaceuticals and Medical Devices Agency in Japan to seek manufacturing and marketing approval for Teva's fremanezumab. The application is for the indication of preventive treatment of migraine.

Fremanezumab is an anti-CGRP (calcitonin gene-related peptide) monoclonal antibody, administered as a subcutaneous injection for the prevention of chronic and episodic migraine attacks. It is thought that fremanezumab, by targeting the CGRP ligand, inhibits its binding to the CGRP receptor, thereby preventing migraine.

In 2017, Otsuka entered into an exclusive licensing agreement with Teva for development and sales in Japan. Earlier this year, the two companies announced outcomes from two, pivotal phase 2/3 trials in Japan for fremanezumab. Subjects with chronic migraine (15 or more headache days per month and eight or more migraine days per month) were assessed in one trial and subjects with episodic migraine (between six and 14 headache days per month and four or more migraine days per month) were assessed in the other trial.

In both trials, primary endpoints were achieved with clinical and statistical significance versus placebo. Improvements versus placebo were also shown for secondary endpoints in both trials. No clinically significant adverse events were observed in subjects who received fremanezumab.

A significant unmet medical need exists for patients in Japan with migraine. This is evidenced, for example, by a large retrospective analysis in Japan which showed that a significant proportion of patients who began to receive prophylactic treatment for migraine subsequently discontinued treatment.1 Many of the patients later reinitiated the same treatment or switched treatment, whereas others permanently discontinued treatment.

Teva obtained regulatory approvals for fremanezumab in the U.S. in 2018 and in Europe in 2019, and it is currently available to patients in these regions under the brand name Ajovy®.

  1. 1Real world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme. J Headache Pain 20: 68 (2019).

Information in this news release was current as of the original release date.

永安宝禄光贸易有限公司

Most Recent Releases

香蕉视频下载app 榴莲视频app下载 趣播app下载 光棍影院下载app 含羞草视频下载app 探花直播下载app 向日葵app下载 9uu下载app 夜魅直播app下载 樱花下载app 压寨直播下载app视频免费最新 向日葵下载app 蝶恋花app下载 91视频下载app 红玫瑰直播下载app 四虎下载app 樱桃视频下载app 鲍鱼视频app下载 依恋直播app下载 可乐视频app下载 酷咪直播app下载 七仙女直播下载app 柚子直播app下载 97豆奶视频下载app 水晶直播下载app 爱爱视频app下载 木瓜视频下载app 蚪音下载app 夜夜直播下载app 富二代f2app下载 成版人快手下载app 黄瓜视频app下载 成版人短视频app下载 花椒直播下载app 黄页荔枝下载app视频免费最新 桃花app下载 茄子视频下载app 黄鱼视频下载app 91直播app下载 成版人快手app下载 主播大秀app下载 富二代下载app 猫咪视频下载app 成版人音色短视频下载app视频免费最新 午夜直播app下载 Avnight下载app 7秒鱼直播下载app 午夜直播下载app 成人快手下载app 月亮视频app下载 七仙女直播app下载 樱桃视频app下载 小奶狗视频下载app 梦幻直播下载app 茄子下载app 富二代f2下载app 牛牛视频下载app 橙子直播下载app 91视频app下载 猛虎直播app下载 成版人茄子视频app下载 东京视频app下载 小狐仙直播app下载 可乐视频app下载 春水堂视频app下载 成版人快手app下载 月光直播下载app 主播大秀下载app 水果视频下载app 富二代app下载 烟花直播app下载 AVnight下载app 迷雾直播下载app 污软件app下载 春水堂视频下载app 十里桃花直播下载app 小宝贝直播下载app 年华直播下载app视频免费最新 荔枝app下载 茄子视频下载app 荔枝下载app Avboboapp下载 花姿下载app 大菠萝下载app 笔芯直播下载app 幸福宝app下载 音色短视频下载app 小奶猫下载app 水晶直播下载app 丝瓜视频污下载app 黄鱼视频下载app视频免费最新 乐购直播下载app 恋人直播app下载 红玫瑰直播下载app 91香蕉视频下载app 小小影视app下载 木瓜下载app 咪哒直播下载app AVBOBOapp下载 月亮直播app下载 猫咪视频app下载 樱花视频app下载 荔枝app下载 尤蜜下载app 烟花直播app下载 香草成视频人下载app 泡芙短视频下载app 好嗨哟直播下载app 蜜橙视频app下载 荔枝app下载 小v视频下载app 小天仙直播app下载 樱桃直播app下载 米老鼠直播下载app 9uuapp下载 小狐仙直播app下载 暗夜直播下载app 秀儿直播下载app 茄子直播下载app 大象视频app下载 秀儿直播app下载 大小姐直播下载app 成版人音色短视频下载app视频免费最新 初恋直播app下载 卡哇伊直播app下载 杏花直播app下载 富二代app下载 么么直播下载app 豆奶抖音短视频下载app 花心视频app下载 泡泡直播app下载 黄瓜下载app 花样视频下载app视频免费最新 Kitty直播app下载 猛虎视频下载app 蓝精灵直播下载app 梦鹿直播下载app 铁牛app下载 柠檬视频app下载 合欢视频app下载 番茄直播app下载 BB直播app下载 月亮视频下载app 黄鱼视频下载app 含羞草视频下载app 鲍鱼视频下载app 91直播app下载 望月下载app 小喵直播app下载 柚子直播下载app 春水堂视频app下载 花姬直播app下载 成人快手app下载 午夜直播下载app 花姿app下载 杏趣直播下载app 老王视频app下载 蜜桃app下载 咪哒app下载 可乐视频下载app视频免费最新 樱花雨直播app下载 7秒鱼直播app下载 花姿app下载 幸福宝app下载 萝卜视频app下载 薰衣草直播app下载 swag台湾下载app 小酒窝直播app下载 黄瓜视频人下载app 繁花直播app下载 小可爱下载app f2富二代下载app 大秀直播app下载 小宝贝直播下载app 成人快手app下载 红楼直播app下载 夏娃直播下载app视频免费最新 咪哒直播下载app 小喵直播app下载 后宫下载app视频免费最新 月色直播下载app 牛牛视频下载app 爱爱视频下载app 成版人茄子视频下载app 泡芙短视频app下载 粉色视频app下载 小奶狗视频app下载 芭乐视频app下载 杏吧直播app下载 污直播下载app 月光宝盒直播app下载 芭乐视频app下载 富二代短视频下载app 樱花下载app视频免费最新 6房间视频直播app下载 初恋视频下载app 橘子视频下载app 菠萝蜜视频下载app 7秒鱼下载app 小仙女app下载 火爆社区下载app视频免费最新 菠萝蜜下载app 小奶狗视频下载app 秀色直播下载app 香草成视频人下载app视频免费最新 梦幻直播下载app 可乐视频下载app 小宝贝直播下载app 樱花下载app 小狐仙直播app下载 久草下载app 陌秀直播app下载 污软件下载app视频免费最新 小奶狗app下载 趣播app下载 花姿直播app下载 抖阴直播下载app 大番号app下载 草鱼app下载 月色直播app下载 柠檬视频app下载 烟花巷app下载 榴莲视频下载app 花姿下载app视频免费最新 朵朵直播app下载